Public health & disease

Aerial view of Gaza City

More than 350,000 Gazan children vaccinated against polio

| By | -, Change Milestones

Thousands of families visited health centers to get doses from U.N. medical teams, UNRWA reported. In southern Gaza, more than 152,000 children were vaccinated in Khan Younis city, nearly 8,800 in Rafah, and another 1,000 elsewhere in the south. The promising development follows the successful completion of the first phase of the vaccination campaign in central Gaza earlier this week, which saw more than 187,000 children under 10 receive protection from polio. To date, combined coverage for central and southern Gaza now stands at 354,786 children.

More than 350,000 Gazan children vaccinated against polio Read more

Anchorage, Alaska, USA

Nurse practitioners can provide abortions in Alaska, judge rules

| By | -, Change Milestones

A judge has struck down an Alaska law banning qualified nurse practitioners and physician assistants from performing abortions, siding with a legal challenge by a Planned Parenthood affiliate. Alaska Superior Court Judge Josie Garton in Anchorage has ruled that the law violated Alaskans’ rights to privacy and equal protection under the state constitution. The state’s top court found that those rights include a right to abortion in a 1997 ruling, and abortion is legal in the state at all stages of pregnancy.

Nurse practitioners can provide abortions in Alaska, judge rules Read more

South Korean flags

‘Major milestone’ immunization campaign begins in North Korea with support of UNICEF

| By | -, Change Milestones

More than 800,000 children and 120,000 pregnant women will be vaccinated in a nationwide campaign launched on Monday by the Government of the Democratic People’s Republic of Korea (DPRK) with the support of the UN Children’s Fund (UNICEF). Over four million doses of essential vaccines — including Pentavalent, Measles-Rubella (MR), Tetanus-Diphtheria, BCG, Hepatitis B, and Inactivated Poliovirus Vaccine (IPV) — were delivered to the DPRK in July to kickstart this comprehensive catch-up effort.

‘Major milestone’ immunization campaign begins in North Korea with support of UNICEF Read more

Person touching pregnant belly with hands forming a heart

Aetna to start covering IUI in the U.S.

| By | -, Change Milestones

Medical insurance company Aetna just announced that it’s going to be providing additional fertility coverage, specifically offering intrauterine insemination (IUI), to all policyholders regardless of sexual orientation or whether they’re partnered. This comes after a settlement agreement from a lawsuit earlier this year which stated that Aetna has to provide such care for LGBTQ+ people. The case, Goidel et al. v. Aetna, was filed in September 2021 and only came to a resolution in May after years of waiting and legal battles.

Aetna to start covering IUI in the U.S. Read more

Model lungs

World-first lung cancer vaccine trials launched across seven countries

| By | -, Change Milestones

Lung cancer is the world’s leading cause of cancer death, accounting for about 1.8 million deaths every year. Now experts are testing a new jab that instructs the body to hunt down and kill cancer cells – then prevents them from ever coming back. Known as BNT116 and made by BioNTech, the vaccine is designed to treat non-small cell lung cancer, the most common form of the disease. The phase 1 clinical trial, the first human study of BNT116, has launched across 34 research sites in seven countries: the U.K., U.S., Germany, Hungary, Poland, Spain, and Turkey.

World-first lung cancer vaccine trials launched across seven countries Read more

Honeycomb

Manuka honey reduces breast cancer cell growth by 84% in preliminary studies

| By | -, Change Milestones

Manuka honey is produced from the nectar collected by honey bees when they pollinate the mānuka, a species of tea tree indigenous to New Zealand and southeast Australia. Now, preliminary studies by researchers at UCLA have found that this nutraceutical might aid in breast cancer prevention and treatment. The honey-treated mice showed significantly suppressed tumor growth compared to controls. Overall, it inhibited the growth and progression of an established human breast cancer tumor by 84% without affecting healthy cells.

Manuka honey reduces breast cancer cell growth by 84% in preliminary studies Read more

MIT naloxone sensor implant

MIT scientists reverse opioid overdoses with ‘Narcan sensor’ implanted under skin

| By | -, Change Milestones

In 2023, more than 100,000 Americans died from opioid overdoses. The most effective way to save someone who has overdosed is to administer a drug called naloxone, but help can’t always reach the person in time. Researchers at MIT and Brigham and Women’s Hospital have developed a new device to address this problem. The device, about the size of a stick of gum, can be implanted under the skin. When it determines that an overdose has occurred, it rapidly pumps out a dose of naloxone.

MIT scientists reverse opioid overdoses with ‘Narcan sensor’ implanted under skin Read more

Medications

The U.S. negotiates Medicare drug price cuts that will save billions for U.S. citizens

| By | -, Change Milestones

The United States has negotiated down the prices of 10 top-selling prescription drugs used by Medicare by as much as 79%, hoping to save $6 billion in the first year as part of a plan hailed on Thursday by President Joe Biden with the aim to ease anger about high prices ahead of November elections. Biden’s signature Inflation Reduction Act, signed into law in 2022, was the first to allow Medicare to negotiate prices for some of the most costly drugs that the program covers for 66 million people. The new prices will go into effect in 2026.

The U.S. negotiates Medicare drug price cuts that will save billions for U.S. citizens Read more

Vials of blood

U.S. Food and Drug Administration approves blood test to screen for colon cancer

| By | -, Change Milestones

The test, known as Shield, isn’t meant to replace colonoscopies, but is generating enthusiasm among doctors who say it has the potential to boost the dismal rate of screenings for the second-highest cause of cancer death in the United States. Shield has previously been available to doctors as a screening tool, at an out-of-pocket cost of $895. With the FDA approval, Medicare and private insurance companies are much more likely to cover the cost of the blood test, making it more widely accessible for patients.

U.S. Food and Drug Administration approves blood test to screen for colon cancer Read more

HIV virus

New twice-yearly shot to prevent HIV achieves 100% success rate in late-stage trial

| By | -, Change Milestones

In this double-blind, randomized study of 5,300 cisgender women in South Africa and Uganda, 2,134 got the injection and the others took one of two types of daily PrEP pills. The trial from California-based company Gilead Sciences began on August 2021 and, so far, not a single woman who received the injections has contracted HIV. The participants who received either of the oral PrEP options, Truvada and Descovy, had infection rates of about 2% — consistent with the infection rates of oral PrEP in other clinical trials.

New twice-yearly shot to prevent HIV achieves 100% success rate in late-stage trial Read more

Start typing and press enter to search